rs7988338

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_033012.4(TNFSF11):​c.-159-874G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.178 in 152,062 control chromosomes in the GnomAD database, including 2,632 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 2632 hom., cov: 32)

Consequence

TNFSF11
NM_033012.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.447

Publications

16 publications found
Variant links:
Genes affected
TNFSF11 (HGNC:11926): (TNF superfamily member 11) This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found. [provided by RefSeq, Jul 2008]
TNFSF11 Gene-Disease associations (from GenCC):
  • autosomal recessive osteopetrosis 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp
  • autosomal recessive osteopetrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_033012.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033012.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFSF11
NM_033012.4
c.-159-874G>A
intron
N/ANP_143026.1O14788-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFSF11
ENST00000358545.6
TSL:1
c.-159-874G>A
intron
N/AENSP00000351347.2O14788-2

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
27038
AN:
151946
Hom.:
2622
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.143
Gnomad AMI
AF:
0.199
Gnomad AMR
AF:
0.297
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.310
Gnomad SAS
AF:
0.118
Gnomad FIN
AF:
0.129
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.174
Gnomad OTH
AF:
0.183
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.178
AC:
27064
AN:
152062
Hom.:
2632
Cov.:
32
AF XY:
0.177
AC XY:
13157
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.143
AC:
5922
AN:
41484
American (AMR)
AF:
0.298
AC:
4555
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
638
AN:
3468
East Asian (EAS)
AF:
0.309
AC:
1599
AN:
5176
South Asian (SAS)
AF:
0.119
AC:
570
AN:
4800
European-Finnish (FIN)
AF:
0.129
AC:
1364
AN:
10556
Middle Eastern (MID)
AF:
0.130
AC:
38
AN:
292
European-Non Finnish (NFE)
AF:
0.174
AC:
11814
AN:
67978
Other (OTH)
AF:
0.181
AC:
383
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1121
2242
3363
4484
5605
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.182
Hom.:
4059
Bravo
AF:
0.194
Asia WGS
AF:
0.207
AC:
720
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
2.0
DANN
Benign
0.38
PhyloP100
0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7988338;
hg19: chr13-43144842;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.